TMO

Thermo Fisher Scientific Inc. [TMO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TMO Stock Summary

Top TMO Correlated Resources

TMO


Top 10 Correlated ETFs

TMO


Top 10 Correlated Stocks

TMO


In the News

08:16 10 Dec 2023 TMO

New Strong Sell Stocks for December 6th

AESI, EQH and TMO have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2023.

07:31 10 Dec 2023 TMO

Thermo Fisher (TMO) Advances Health Equity via New Partnership

Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.

11:05 10 Dec 2023 TMO

Thermo Fisher Scientific: A Good Buy Near The Bottom

Thermo Fisher Scientific is facing temporary revenue headwinds due to reduced COVID-19-related sales and cautious customer spending. The company's organic revenues are expected to bottom in FY24 and see a reacceleration in growth from FY25 onwards which can help the stock re-rate. TMO's valuation is cheap compared to historical averages and peers, offering a good buying opportunity.

01:32 10 Dec 2023 TMO

Thermo Fisher (TMO) Extends Partnership With Flagship Pioneering

Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.

12:30 10 Dec 2023 TMO

3 High Dividend Growth Stocks to Buy in December 2023

After a downturn that ran from late summer to early fall, the stock market reversed higher on two pieces of good news. First, inflation seems to have stabilized.

09:56 10 Dec 2023 TMO

Thermo Fisher Scientific reveals new $4B stock buyback program

Thermo Fisher Scientific (NYSE:TMO) Inc has announced a new $4 billion stock repurchase program, which represents about 2.3% of its market capitalization of $171.99 billion as of Monday's close.  The analytics, diagnostics and laboratory services company said the new buyback program, which has no expiration date, replaces the existing program that had $1 billion in repurchase authorization remaining.

08:08 10 Dec 2023 TMO

Thermo Fisher sets new $4 billion stock buyback program, about 2 weeks after shares hit a 3-year low

Shares of Thermo Fisher Scientific Inc. TMO, -0.73% were little changed in premarket trading Tuesday, after the analytics, diagnostics and laboratory services company announced a new $4 billion stock repurchase program. The new program represents about 2.3% of the company's market capitalization of $171.99 billion as of Monday's close.

09:37 10 Dec 2023 TMO

Down 19% in 2023 So Far, Is Thermo Fisher Scientific Stock Still Worth Buying?

Thermo Fisher is seeing the collapse of its COVID-19 diagnostic business. It's also suffering from its customers tightening their purse strings.

09:57 10 Dec 2023 TMO

Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?

Thermo Fisher and Abbott are two of our key Healthcare holdings in our fund, and both are among our top 10 holdings overall. Abbott and Thermo Fisher focus on different industries which are Healthcare Equipment and Life Science Tools respectively. Both show strong revenue growth compared to the market average growth rate which indicates that both companies exhibit competitive advantages within their respective main markets.

05:57 10 Dec 2023 TMO

3 Beaten-Down Dividend Stocks You Could Regret Not Buying on the Dip

Ally Financial is a digital bank that offers a dividend yield above 5% at recent prices. Thermo Fisher Scientific's COVID-19 testing revenue has evaporated, but that won't stop the company from raising its dividend payout higher in the years ahead.

TMO Financial details

Company Rating
Strong Buy
Market Cap
189.23B
Income
5.94B
Revenue
43.42B
Book val./share
117.48
Cash/share
15.94
Dividend
1.35
Dividend %
0.28%
Employees
130K
Optionable
No
Shortable
Yes
Earnings
30 Jan 2024
P/E
31.82
Forward P/E
22.26
PEG
-14.59
P/S
4.36
P/B
4.17
P/C
30.73
P/FCF
28.91
Quick Ratio
1.03
Current Ratio
1.63
Debt / Equity
0.78
LT Debt / Equity
0.67
-
-
EPS (TTM)
15.34
EPS next Y
22
EPS next Q
5.63
EPS this Y
-9.63%
EPS next Y
43.42%
EPS next 5Y
32.4%
EPS last 5Y
19.39%
Revenue last 5Y
13.02%
Revenue Q/Q
-1.06%
EPS Q/Q
25.78%
-
-
-
-
SMA20
9.53%
SMA50
-2.15%
SMA100
-6.44%
Inst Own
61.99%
Inst Trans
0.71%
ROA
6%
ROE
14%
ROC
0.08%
Gross Margin
41%
Oper. Margin
16%
Profit Margin
14%
Payout
8%
Shs Outstand
386.37M
Shs Float
385.55M
-
-
-
-
Target Price
639.71
52W Range
415.6-609.85
52W High
-19.58%
52W Low
+18.02%
RSI
57.66
Rel Volume
1.02
Avg Volume
1.83M
Volume
1.87M
Perf Week
-0.64%
Perf Month
11.27%
Perf Quarter
-7.14%
Perf Half Y
-5.95%
-
-
-
-
Beta
0.813
-
-
Volatility
2.17%, 21.22%
Prev Close
-0.88%
Price
489.77
Change
-0.96%

TMO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
60.5963.8681.3699.52114.58
Net income per share
7.319.2416.119.6117.73
Operating cash flow per share
11.312.4320.9324.2223.35
Free cash flow per share
9.4210.1217.2117.8217.63
Cash per share
5.23626.0711.3621.74
Book value per share
68.6274.1987.1485.13112.33
Tangible book value per share
-31.69-25.13-10.65-157.14-36.96
Share holders equity per share
68.6274.1987.1485.13112.33
Interest debt per share
48.946.0756.2889.8689.83
Market cap
89.96B129.95B184.45B262.89B215.87B
Enterprise value
106.85B145.3B195.86B293.29B241.83B
P/E ratio
30.6235.1628.9334.0331.06
Price to sales ratio
3.695.095.736.74.81
POCF ratio
19.826.1322.2527.5523.58
PFCF ratio
23.7732.1127.0737.4531.24
P/B Ratio
3.264.385.357.844.9
PTB ratio
3.264.385.357.844.9
EV to sales
4.395.696.087.485.38
Enterprise value over EBITDA
17.1121.9819.224.1120.06
EV to operating cash flow
23.5229.2223.6330.7326.42
EV to free cash flow
28.2335.928.7441.7834.99
Earnings yield
0.030.030.030.030.03
Free cash flow yield
0.040.030.040.030.03
Debt to equity
0.690.60.631.040.78
Debt to assets
0.340.310.310.370.35
Net debt to EBITDA
2.72.321.122.52.15
Current ratio
1.711.912.131.51.48
Interest coverage
5.676.814.0918.7111.56
Income quality
1.551.351.31.231.32
Dividend Yield
00000
Payout ratio
0.090.080.050.050.07
Sales general and administrative to revenue
00000
Research and developement to revenue
0.040.040.040.040.03
Intangibles to total assets
0.720.680.560.650.6
Capex to operating cash flow
-0.17-0.19-0.18-0.26-0.25
Capex to revenue
-0.03-0.04-0.05-0.06-0.05
Capex to depreciation
-0.33-0.41-0.63-0.97-0.66
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
106.23124.19177.66193.79211.68
ROIC
0.050.060.090.090.07
Return on tangible assets
0.190.20.210.240.18
Graham Net
-54.45-52.92-45.2-207.32-90.8
Working capital
4.42B5.66B11.65B6.73B8.25B
Tangible asset value
-12.74B-10.05B-4.22B-61.92B-14.49B
Net current asset value
-17.96B-16.65B-12.59B-74.6B-27.78B
Invested capital
0.690.60.631.040.78
Average receivables
4.01B4.24B5.05B6.86B8.13B
Average payables
1.52B1.77B2.05B2.52B3.12B
Average inventory
2.99B3.19B3.7B4.54B5.34B
Days sales outstanding
61.9862.1565.0474.2567.24
Days payables outstanding
45.3751.150.5255.1448.56
Days of inventory on hand
84.4189.6993.5997.1580.91
Receivables turnover
5.895.875.614.925.43
Payables turnover
8.057.147.226.627.52
Inventory turnover
4.324.073.93.764.51
ROE
0.110.120.180.230.16
Capex per share
-1.89-2.32-3.72-6.4-5.72

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-10-012022-12-312023-04-012023-07-01 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
27.2429.2827.7527.6927.39
Net income per share
3.814.033.343.534.44
Operating cash flow per share
4.948.921.893.996.25
Free cash flow per share
3.557.510.73.255.39
Cash per share
7.4521.89.028.1215.94
Book value per share
111.24112.61109.61113.48117.48
Tangible book value per share
-37.18-37.06-48.39-43.51-39.4
Share holders equity per share
111.24112.61109.61113.48117.48
Interest debt per share
74.8388.8992.1288.9592.34
Market cap
198.82B215.32B222.48B201.4B195.38B
Enterprise value
225.06B241.28B254.25B232.27B224.51B
P/E ratio
33.2534.1643.1536.9928.48
Price to sales ratio
18.6218.8120.7718.8418.48
POCF ratio
102.6461.75305.18130.7880.94
PFCF ratio
143.0373.31820.96160.3593.84
P/B Ratio
4.564.895.264.64.31
PTB ratio
4.564.895.264.64.31
EV to sales
21.0821.0723.7421.7321.23
Enterprise value over EBITDA
85.0981.8296.5383.1373.35
EV to operating cash flow
116.1969.2348.77150.8393.01
EV to free cash flow
161.9182.15938.21184.93107.84
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.010.0100.010.01
Debt to equity
0.670.780.830.780.78
Debt to assets
0.320.350.370.360.36
Net debt to EBITDA
9.928.812.0611.059.52
Current ratio
1.741.481.271.421.63
Interest coverage
9.886.925.214.845.19
Income quality
1.292.220.561.131.42
Dividend Yield
00000
Payout ratio
0.080.070.090.10.08
Sales general and administrative to revenue
00000
Research and developement to revenue
0.030.030.030.030.03
Intangibles to total assets
0.640.60.650.650.63
Capex to operating cash flow
-0.28-0.16-0.63-0.18-0.14
Capex to revenue
-0.05-0.05-0.04-0.03-0.03
Capex to depreciation
-0.65-0.65-0.53-0.33-0.39
Stock based compensation to revenue
0.010.010.01-0.01-0.01
Graham number
97.7101.0690.7594.88108.37
ROIC
0.020.020.010.010.02
Return on tangible assets
0.050.040.040.040.05
Graham Net
-89.99-91.04-103.55-99-94.46
Working capital
8.18B8.25B4.33B5.88B8.93B
Tangible asset value
-14.57B-14.49B-18.68B-16.8B-15.21B
Net current asset value
-27.51B-27.78B-32.02B-30.2B-28.5B
Invested capital
0.670.780.830.780.78
Average receivables
7.71B7.97B8.1B7.97B8.19B
Average payables
2.53B2.93B3.09B2.61B2.47B
Average inventory
5.7B5.68B5.65B5.66B5.53B
Days sales outstanding
64.6665.0466.5767.5371.24
Days payables outstanding
35.6145.3139.1234.4936.73
Days of inventory on hand
82.4575.5179.1980.4979.15
Receivables turnover
1.391.381.351.331.26
Payables turnover
2.531.992.32.612.45
Inventory turnover
1.091.191.141.121.14
ROE
0.030.040.030.030.04
Capex per share
-1.4-1.41-1.19-0.74-0.86

TMO Frequently Asked Questions

What is Thermo Fisher Scientific Inc. stock symbol ?

Thermo Fisher Scientific Inc. is a US stock , located in Waltham of Ma and trading under the symbol TMO

Is Thermo Fisher Scientific Inc. buy or a sell ?

26 stock analysts have 26 predictions with a medium analyst target price of $635.38. The lowest prediction is $505 and the highest is $711

What is TMO stock prediction ?

With a median analyst target price of $530, 1 stock analysts have made 1 forecasts in last 90 days. $530 is the lowest and $530 is the greatest projection.

What is Thermo Fisher Scientific Inc. stock quote today ?

Thermo Fisher Scientific Inc. stock price is $489.77 today.

Is Thermo Fisher Scientific Inc. stock public?

Yes, Thermo Fisher Scientific Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks